BiotechTube
Home/Pangolin Therapeutics/Enrique Alvarez Sotomayor
EA

Enrique Alvarez Sotomayor

Co-Founder and CEO

Pangolin Therapeutics

Therapeutic Areas

OncologyImmunologyMetabolic DiseaseNeurodegeneration

Pangolin Therapeutics Pipeline

DrugIndicationPhase
Undisclosed (Targeting IAPP)Type 2 DiabetesPre-clinical
Undisclosed (Targeting alpha-synuclein)Neurodegeneration (e.g., Parkinson's Disease)Pre-clinical

Leadership Team at Pangolin Therapeutics

AM
Andrew Miranker, PhD
Co-Founder, Scientific Advisory Board Chair
View full Pangolin Therapeutics profile